David Gobel
Förmögenhet: 4 365 $ per 2026-08-31
Förmögenhet: 4 365 $ per 2026-08-31
Mr. David Gobel is an Independent Director at VivoSim Labs, Inc., a Chairman at Turn Biotechnologies, Inc., a Chief Executive Officer at Methuselah Capital Management LLC, a Chief Executive Officer at Methuselah Funds LLC, an Independent Director at Oisin Biotechnologies, Inc. and a Chief Executive Officer at Methuselah Foundation.
He is on the Board of Directors at VivoSim Labs, Inc., Leucadia Therapeutics, Inc. and Oisin Biotechnologies, Inc. Mr. Gobel was previously employed as a Chief Venture Strategist by Transportation Security Administration.
He also served on the board at Volumetric Biotechnologies, Inc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VIVOSIM LABS INC 0,58 % | 2026-08-13 | 15 000 ( 0,58 % ) | 4 365 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| VIVOSIM LABS, INC. | Direktör/Styrelseledamot | 2020-09-15 |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Direktör/Styrelseledamot | 2014-12-01 |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Verkställande Direktör | 2017-01-01 |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Direktör/Styrelseledamot | 2015-10-01 |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Verkställande Direktör | 2001-09-01 |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Ordförande | 2020-05-01 |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Verkställande Direktör | 2016-12-01 |
| Företag | Position | Slut |
|---|---|---|
Volumetric Biotechnologies, Inc. | Direktör/Styrelseledamot | 2020-01-01 |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Företagsledare/Principal | 2013-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
VivoSim Labs, Inc.
VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Government |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Miscellaneous |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Health Technology |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Volumetric Biotechnologies, Inc. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån